Biotech firm Dyne Therapeutics nabs $50 mln Series A
Cambridge, Massachusetts-based Dyne Therapeutics, a new biotechnology company, has secured $50 million in Series A funding. The investors were Atlas Venture, Forbion and MPM Capital.
4 April 2019•1 min read
